Downloadable Slides

RELEASE DATE:    THURSDAY, NOVEMBER 6, 2014    
EXPIRATION DATE:    THURSDAY, NOVEMBER 5, 2015

Downloadable Slide Deck (Non-Certified Educational Resource)

This non-CME resource tool was developed under the Auspices of Albert Einstein College of Medicine of Yeshiva University and AXIS Medical Education from the proceedings of a CME activity entitled, “The Chronic Lymphocytic Leukemia Revolution Latest Treatment Advances”.  This tool is supported by an educational grant from Genentech and designed for hematologists, oncologists and the interdisciplinary healthcare team responsible for the management of patients with chronic lymphocytic leukemia (CLL).

Hematologists and oncologists need to understand the latest clinical research that is expanding treatment options for CLL, especially in the elderly population where comorbidities are present. Understanding these new treatment approaches will allow clinicians to optimally incorporate new safety and efficacy data into their treatment strategies and appropriately choose therapy for CLL patients with comorbidities. 
 
Faculty involved with the development of the content include:
Mark A. Weiss, MD - Chairperson
Director of the Hematologic Malignancies &
Hematopoietic Stem Cell Transplantation Division
Thomas Jefferson University/Sidney Kimmel Medical College
Jefferson University Hospitals
Philadelphia, Pennsylvania
 
Amit Verma, MD - Peer Reviewer
Professor, Department of Medicine (Oncology)
Professor, Department of Developmental & Molecular Biology
Albert Einstein College of Medicine of Yeshiva University
Montefiore Medical Center
Bronx, New York


Jointly provided by:

 
Format: Microsoft PowerPoint (.ppt) | File size: 4.9 MB | Date posted: 11/6/2014

Slide Deck Disclaimer

This slide deck in its original and unaltered format is for educational purposes and is current as of August 2014. All materials contained herein reflect the views of the faculty, and not those of AXIS, the CME provider, or the commercial supporter. These materials may discuss therapeutic products that have not been approved by the US Food and Drug Administration and off-label uses of approved products. Readers should not rely on this information as a substitute for professional medical advice, diagnosis, or treatment. The use of any information provided is solely at your own risk, and readers should verify the prescribing information and all data before treating patients or employing any therapeutic products described in this educational activity.

Usage Rights

This slide deck is provided for educational purposes and individual slides may be used for personal, non-commercial presentations only if the content and references remain unchanged. No part of this slide deck may be published in print or electronically as a promotional or certified educational activity without prior written permission from AXIS. Additional terms may apply. See Terms of Service for details.